BioMark Diagnostics, Inc. (BUX.CX)

0.60 +0.02 (+3.45%) CAD  |  CNSX  |  Apr 02, 15:58
More

BioMark Diagnostics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for BUX.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Justera Health Ltd. --
Neural Therapeutics, Inc. --
ARCpoint, Inc. --
Arch Biopartners, Inc. Upgrade
Biocure Technology, Inc. --